Stage I Prostate Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

Also known as: Prostate cancer stage I / Carcinoma of the prostate stage I / Prostatic cancer stage I

IndicationStatusPhase
DBCOND0028877 (Stage I Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00103194Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate CancerTreatment